Unlock the Power of AI with Our Experienced Team

Our Team

Our team of AI advisors is dedicated to delivering tailored solutions that are tailored to our clients’ needs, and we go the extra mile to ensure that you get the most out of your AI investments. We also specialise in building the health economic case in healthcare systems for vaccines, therapeutics and digital interventions. We pay attention to every detail to ensure that our clients get the best possible advice and guidance. Get in touch with us to start working with our team and discover the potential of AI.

Jackie Hunter (CEO)

Jackie has a wealth of experience in the Life Sciences especially the pharmaceutical industry. She was an early adopter of AI in drug discovery, establishing the drug discovery and development arm of BenevolentAI and serving as a Board director of the company. She chairs the Boards of several AI companies and has acted as a mentor to a number of start ups. She is also on the Board of A*Star in Singapore and Chairs their digital health accelerator.

Nichola Naylor (VP Health Economics)

Nichola has over a decade of experience in constructing economic models to understand the economic burden of diseases and/or the efficiency of interventions within the healthcare sector. She was an early adopter of R for health economics, writing tutorial papers and conducting online and in-person courses, through posts at the London School of Hygiene and Tropical Medicine, Imperial College London and Harvard University. She was also part of a Wellcome-prize-winning team re-using health data efficiently through R. She has provided expert opinion to the World Health Organisation, the OECD, European Buyers groups and the UK Parliamentary Office.

Pamela Spence (Partner Associate)

Pamela Spence began her career in drug discovery at ICI (now AstraZeneca), combining a passion for innovation with a deep curiosity for human biochemistry, before developing an aptitude for business strategy, commercial returns and economic markets and qualifying as a Chartered Accountant in 1994. As a Partner at EY, she founded the UK Health and Life Sciences industry practice and went on to grow and lead the global practice to more than $4 billion in revenue and 38,000 people, working closely with boards and senior executives in complex, high-pressure environments. She also represented EY’s European client-facing Partners for six years on the Global Accounts Committee, helping shape the strategy, governance, talent and resource frameworks supporting the firm’s largest multinational clients. After eight years operating within EY’s global leadership, Pamela led the redesign of its learning and development programme for client-facing leaders. Following 34 years in global professional services, she founded Qjarli in late 2025, an independent learning and development studio focused on helping executives become more purposeful leaders, execute more impactful strategies, build stronger trust-based business relationships and win the business they most want.

Lily (Director of Wellbeing and Treat Acquisitions)

Lily has extensive experience in boosting team morale, supervising snack distribution and ensuring regular breaks are taken. A strong advocate for workplace wellbeing, she specialises in strategic napping, enthusiastic greetings and identifying treat-related opportunities across the organisation.

AI and ML have the potential to revolutionise research and development as well as reduce costs and increase productivity. However many organisations have failed to realise the potential of AI. We can help organisations implement technology efficiently.

Contact